Efficacy and safety of the endothelin a/b receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering committee on behalf of the UK/Netherlands/Eire TAK-044 subarachnoid haemorrhage study group

MDM Shaw, M Vermeulen, GD Murray, JD Pickard, BA Bell, GM Taesdale, Djo Hasan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)992-997
Number of pages6
JournalJournal of Neurosurgery
Publication statusPublished - 2000

Research programs

  • EMC 05-02-44-04-01

Cite this